Dirk P. van Asseldonk

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

J.‐F. Rahier, Pavol Papay, Julia Salleron et al. · Gut · 2011 · 79 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement

Bindia Jharap, Dirk P. van Asseldonk, Nanne K.H. de Boer et al. · PLoS ONE · 2015 · 60 citations · Full text

Medicine, Internal Medicine, Pathology +15

Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice.

Margien L. Seinen, Dirk P. van Asseldonk, Chris J. Mulder et al. · PubMed · 2010 · 50 citations

Medicine, Pharmacology, Pharmacotherapy +14

The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: Results from a prospective pharmacological study

Margien L. Seinen, Dirk P. van Asseldonk, Nanne K.H. de Boer et al. · Journal of Crohn s and Colitis · 2013 · 48 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease

Dirk P. van Asseldonk, Bindia Jharap, Joanne Verheij et al. · Inflammatory Bowel Diseases · 2016 · 45 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14